[
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-1",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#definitiongeneral183948",
    "clean_content": "Definition / general\n\n* Langerhans cell histiocytosis (LCH) is a clonal proliferation of cells that morphologically and immunophenotypically resemble Langerhans cells"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-2",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#essentialfeatures183949",
    "clean_content": "Essential features\n\n* Langerhans cell histiocytosis is a clonal proliferation of cells that morphologically and immunophenotypically resemble Langerhans cells* More common in childhood (1 - 3 years old) and involves nodal and extranodal sites (most common site is bone)* Lesional cells show prominent nuclear grooves with admixed eosinophils and are positive for CD1a, langerin (CD207) and S100* Most cases harbor *BRAF* V600E mutations and other RAS / MAPK pathway activating mutations ([Blood 2010;116:1919](20519626))* Unifocal disease is generally associated with a good prognosis, whereas multisystem and multifocal disease is associated with poor prognosis"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-3",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#terminology183950",
    "clean_content": "Terminology\n\n* Histiocytosis X* Eosinophilic granuloma (solitary bone lesion)* Hand-Schüller-Christian disease (multiple lesions)* Hashimoto-Pritzker disease* Letterer-Siwe disease (disseminated or visceral involvement)"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-4",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#icdcoding183951",
    "clean_content": "ICD coding\n\n* ICD-10: [C96.0](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C81-C96/C96-/C96.0) - multifocal and multisystemic (disseminated) Langerhans cell histiocytosis* ICD-10: [C96.5](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C81-C96/C96-/C96.5) - multifocal and unisystemic Langerhans cell histiocytosis* ICD-10: [C96.6](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C81-C96/C96-/C96.6) - unifocal Langerhans cell histiocytosis* ICD-O: [9751/3](https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf#page=97) - Langerhans cell histiocytosis, NOS"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-5",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#epidemiology183952",
    "clean_content": "Epidemiology\n\n* More common in childhood (1 - 3 years old)* Incidence: 3 - 5 per million children, 1 - 2 per million adults ([Blood 2015;126:26](25827831))* M > F* Pulmonary Langerhans cell histiocytosis strongly associated with smoking"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-6",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#sites183953",
    "clean_content": "Sites\n\n* Can be unifocal, multifocal but involving a single organ system or involve multiple organs ([Blood 2015;126:26](25827831))* The most common sites involved are bone and adjacent soft tissue* The following sites can also be involved, particularly in multisystem disease (in order of decreasing frequency): bone, skin, bone marrow, lymph nodes, liver, spleen, oral mucosa, lung, central nervous system / pituitary and gastrointestinal tract* Brain involvement can result in a neurodegenerative syndrome; pituitary involvement can present with diabetes insipidus ([Brain 2005;128:829](15705614))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-7",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#pathophysiology183954",
    "clean_content": "Pathophysiology\n\n* The majority of cases are clonal and harbor driver mutations involving the RAS / MAPK pathway ([Blood 2010;116:1919](20519626))* Misguided myeloid / dendritic cell model\n    + Clinical severity and distribution of Langerhans cell histiocytosis lesion(s) may be defined by the cellular stage of myeloid differentiation during which the somatic *BRAF* V600E or other activating kinase mutation arises and results in pathological extracellular signal regulated kinases (ERK) activation ([Br J Haematol 2015;169:3](25430560))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-8",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#etiology183955",
    "clean_content": "Etiology\n\n* Pulmonary Langerhans cell histiocytosis is strongly associated with smoking ([N Engl J Med 2002;346:484](11844849))* Causes for other forms are unknown"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-9",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagrams / tables",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#diagramstables183956",
    "clean_content": "Diagrams / tables\n\nContributed by Vignesh Shanmugam, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam21.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam21.jpg)\n\nMisguided myeloid / dendritic cell model"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-10",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#diagnosis183957",
    "clean_content": "Diagnosis\n\n* Imaging studies ([Blood 2015;126:26](25827831)):\n  + Skeletal survey+ PET-CT scan+ MRI: most effective for brain lesions* Bone marrow biopsy / aspiration in patients with cytopenias* Endoscopy to rule out gastrointestinal involvement in patients with evidence of malabsorption* Biopsy of lesion(s): complete excision is not required, particularly for bone lesions"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-11",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#laboratory183958",
    "clean_content": "Laboratory\n\n* Complete blood count: cytopenias suggest bone marrow involvement ([Blood 2015;126:26](25827831))* Liver function studies: abnormal if liver involved"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-12",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#radiologydescription183959",
    "clean_content": "Radiology description\n\n* Plain radiographs / CT: solitary or multiple punched out lytic lesions without sclerotic rim* MRI: T1 hypointense to isointense, T2 hyperintense, T1 contrast enhancing ([Dähnert: Radiology Review Manual, 6th Edition, 2007](https://www.amazon.com/exec/obidos/ASIN/B01NAO3JG2/pathologyoutl-20))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-13",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#radiologyimages183960",
    "clean_content": "Radiology images\n\nContributed by Vignesh Shanmugam, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam22.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam22.jpg)\n\nSagittal view\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam23.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam23.jpg)\n\nCoronal view\n\n  \n  \nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/lymphnodesLCHradiopaedia01.jpg)](https://radiopaedia.org/articles/langerhans-cell-histiocytosis?lang=us)\n\nLCH"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-14",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#prognosticfactors183961",
    "clean_content": "Prognostic factors\n\n* Localized (single system) disease: good outcome* Multiorgan (2 or more organs) or multisystem disease including liver, spleen or bone marrow: poor outcome ([Blood 2015;126:26](25827831))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-15",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#casereports183962",
    "clean_content": "Case reports\n\n* 2 year old boy with generalized lymphadenopathy, hepatosplenomegaly and lytic lesions ([J Cancer Res Ther 2015;11:1028](26881603))* 7 year old girl with cervical lymphadenopathy ([AABS 2016:3:C79](https://www.pacificejournals.com/journal/index.php/aabs/article/view/aabs1145))* 41 year old woman with skin lesions and generalized lymphadenopathy ([Postepy Dermatol Alergol 2015;32:225](26161066))* 52 year old woman with inguinal lymphadenopathy ([J Clin Pathol 2005;58:104](15623497))* 68 year old woman with small lymphocytic lymphoma / chronic lymphocytic leukemia and rapidly expanding inguinal node ([Case #314](https://www.pathologyoutlines.com/caseofweek/case314.htm))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-16",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Langerhans cell sarcoma",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#langerhanscellsarcoma495758",
    "clean_content": "Langerhans cell sarcoma\n\n* Extremely rare (incidence of 0.2 cases per 10 million) with median overall survival of only 19 months ([Clin Lymphoma Myeloma Leuk 2019;19:441](31005630))* May arise de novo or from Langerhans cell histiocytosis* Shows obliteration of nodal architecture, hypercellularity, nuclear atypia and increase in mitotic activity; some nuclear grooves, occasional multinucleation ([J Clin Exp Hematop 2016;56:109](27980300))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-17",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#treatment183963",
    "clean_content": "Treatment\n\n* Surgical resection may be sufficient for single system disease ([Blood 2015;126:26](25827831))\n  + Curettage may be sufficient for isolated bone lesions* Systemic chemotherapy (vinblastine, prednisone, mercaptopurine)* Smoking cessation for pulmonary Langerhans cell histiocytosis"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-18",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#microscopichistologicdescription183964",
    "clean_content": "Microscopic (histologic) description\n\n* Partial effacement of lymph node with preservation of follicular centers* Infiltration of sinuses by Langerhans cells: 12 - 15 microns in diameter with abundant, pale eosinophilic cytoplasm, irregular and elongated nuclei with prominent nuclear grooves and folds, fine chromatin and indistinct nucleoli ([Arch Pathol Lab Med 2015;139:1211](26414464))* Occasionally multinucleated* Sinuses commonly have foci of necrosis, often surrounded by rim of eosinophils* Variable mitotic activity"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-19",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#microscopichistologicimages183965",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Vignesh Shanmugam, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam04.jpg)\n\nPreservation of follicle centers\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam05.jpg)\n\nSinusoidal infiltration\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam06.jpg)\n\nInfiltrate of subcapsular sinus\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam07.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam07.jpg)\n\nFrequent admixed eosinophils\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam08.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam08.jpg)\n\nProminent nuclear grooves\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam09.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam09.jpg)\n\nAdmixed multinucleated giant cells\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam10.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam10.jpg)\n\nLangerin\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam11.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam11.jpg)\n\nCD1a\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam12.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam12.jpg)\n\nS100\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam13.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam13.jpg)\n\nCyclin D1\n\n  \n  \nContributed by Catherine Hagen, M.D.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen01.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen02.jpg)\n\nLangerhans cell histiocytosis\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen03.jpg)\n\nCD1a positive LCH\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCH_hagen04.jpg)\n\nS100 positive LCH\n\n  \n  \nAFIP images  \n\n[![](https://www.pathologyoutlines.com/imgau/18_01.jpg)](https://www.pathologyoutlines.com/imgau/18_01.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_02.jpg)](https://www.pathologyoutlines.com/imgau/18_02.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_03.jpg)](https://www.pathologyoutlines.com/imgau/18_03.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_04.jpg)](https://www.pathologyoutlines.com/imgau/18_04.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_05.jpg)](https://www.pathologyoutlines.com/imgau/18_05.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_06.jpg)](https://www.pathologyoutlines.com/imgau/18_06.jpg)\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/18_07.jpg)](https://www.pathologyoutlines.com/imgau/18_07.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_08.jpg)](https://www.pathologyoutlines.com/imgau/18_08.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_09.jpg)](https://www.pathologyoutlines.com/imgau/18_09.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_10.jpg)](https://www.pathologyoutlines.com/imgau/18_10.jpg)\n\n[![](https://www.pathologyoutlines.com/imgau/18_11.jpg)](https://www.pathologyoutlines.com/imgau/18_11.jpg)\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/18_12.jpg)](https://www.pathologyoutlines.com/imgau/18_12.jpg)\n\nWith Hodgkin lymphoma\n\n[![](https://www.pathologyoutlines.com/imgau/18_13.jpg)](https://www.pathologyoutlines.com/imgau/18_13.jpg)\n\nInvolving spleen\n\n[![](https://www.pathologyoutlines.com/imgau/18_15.jpg)](https://www.pathologyoutlines.com/imgau/18_15.jpg)\n\nMalignant\n\n[![](https://www.pathologyoutlines.com/imgau/18_16.jpg)](https://www.pathologyoutlines.com/imgau/18_16.jpg)\n\nS100\n\n[![](https://www.pathologyoutlines.com/imgau/03_04.jpg)](https://www.pathologyoutlines.com/imgau/03_04.jpg)\n\nNuclear and cytoplasmic staining S100\n\n  \n  \nCase #314  \n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image10.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image10.jpg)\n\nDiffuse involvement\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image11.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image11.jpg)\n\nSinusoidal and pericapsular involvement\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image12.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image12.jpg)\n \n[![](https://www.pathologyoutlines.com/caseofweek/case314image5.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image5.jpg)\n\nPericapsular involvement\n\n  \n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image6.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image6.jpg)\n\nAdmixed eosinophils\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image7.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image7.jpg)\n\nNuclear grooves\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image8.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image8.jpg)\n\nMitotic activity\n\n  \n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image1CD1a.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image1CD1a.jpg)\n\nCD1a\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image2CD5.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image2CD5.jpg)\n\nCD5\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image3CD20.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image3CD20.jpg)\n\nCD20\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image4CD23.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image4CD23.jpg)\n\nCD23\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image9Langerin.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image9Langerin.jpg)\n\nLangerin\n\n[![](https://www.pathologyoutlines.com/caseofweek/case314image13S100.jpg)](https://www.pathologyoutlines.com/caseofweek/case314image13S100.jpg)\n\nS100"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-20",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#cytologyimages183966",
    "clean_content": "Cytology images\n\nContributed by Vignesh Shanmugam, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam14.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam14.jpg)\n\nProminent nuclear grooves and admixed eosinophils\n\n[![](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam15.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesLCHshanmugam15.jpg)\n\nScattered multinucleated giant cells"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-21",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#positivestains183967",
    "clean_content": "Positive stains\n\n* [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html) ([Histopathology 2002;41:1](12121233))* [Langerin](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207) ([Histopathology 2002;41:1](12121233))* [S100](https://www.pathologyoutlines.com/topic/stainss100.html) ([Histopathology 2002;41:1](12121233))* [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html) ([Histopathology 2002;41:1](12121233),\n        [Blood 2001;97:1241](11222366), [Mod Pathol 2010;23:1616](20729813))* [BRAF VE1](https://www.pathologyoutlines.com/topic/stainsbraf.html) (~50% of cases) ([Hematol Oncol 2018;36:307](28219109))* [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html) ([Histopathology 2002;41:1](12121233))* [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html) ([Histopathology 2002;41:1](12121233))* [Fascin](https://www.pathologyoutlines.com/topic/stainsfascin.html) ([Am J Clin Pathol 2002;118:335](12219775))* [Cyclin D1](https://www.pathologyoutlines.com/topic/stainscyclind1.html) ([Am J Surg Pathol 2017;41:1390](28622183))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-22",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#negativestains183968",
    "clean_content": "Negative stains\n\n* [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html) ([Histopathology 2002;41:1](12121233))* [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html) ([Histopathology 2002;41:1](12121233))* B and T lineage markers (except [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html)) ([Histopathology 2002;41:1](12121233))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-23",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Electron microscopy description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#electronmicroscopydescription183969",
    "clean_content": "Electron microscopy description\n\n* Birbeck granules: tennis racquet shaped, 200 - 400 nm long and 33 nm wide, with a zipper-like appearance ([Mol Biol Cell 2002;13:317](11809842))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-24",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Electron microscopy images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#electronmicroscopyimages183970",
    "clean_content": "Electron microscopy images\n\nAFIP images  \n\n[![](https://www.pathologyoutlines.com/imgau/18_14.jpg)](https://www.pathologyoutlines.com/imgau/18_14.jpg)\n\nBirbeck granules\n\n  \n  \nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/lymphnodesLCHwiki01.jpg)](https://en.wikipedia.org/wiki/Birbeck_granules#/media/File:Langerhans_cell_histiocytosis_-_Birbeck_granules.jpg)\n\nBirbeck granules"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-25",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#molecularcytogeneticsdescription183971",
    "clean_content": "Molecular / cytogenetics description\n\n* ~50% of cases harbor *BRAF* V600E mutations ([Blood 2010;116:1919](20519626))* ~35% of *BRAF* wild type cases show other activating mutations involving the MAPK pathway in a mutually exclusive manner (*MAP2K1* mutations, *BRAF* fusions, *ARAF* mutations, *ERBB3* mutations) ([Blood 2016;128:2533](27729324), [Blood 2014;124:3007](25202140), [Blood 2014;123:3152](24652991), [Blood 2014;124:1655](24982505))* Most cases do not show any cytogenetic abnormalities ([Genes Chromosom Cancer 2009;48:239](19051326))"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-26",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#samplepathologyreport183972",
    "clean_content": "Sample pathology report\n\n* Lymph node, right inguinal, excisional biopsy:\n  + Langerhans cell histiocytosis (see comment)+ Comment: The sections show lymph node tissue with an infiltrate of epithelioid cells involving the interfollicular areas and sinuses. The infiltrate is composed of cells with irregular to folded nuclei with prominent nuclear grooves, vesicular chromatin, distinct nucleoli and moderate amounts of pale eosinophilic cytoplasm. Frequent admixed eosinophils are seen. Reactive appearing germinal centers are relatively preserved.+ Immunohistochemical studies demonstrate that the lesional cells are strongly positive for CD1a, langerin, S100 and cyclin D1."
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-27",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#differentialdiagnosis183973",
    "clean_content": "Differential diagnosis\n\n* [Dermatopathic change](https://www.pathologyoutlines.com/topic/lymphnodesdermatopathiclymphadenitis.html):\n  + Pigment laden macrophages, lacks eosinophils, [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)+ dendritic cells that are [cyclin D1](https://www.pathologyoutlines.com/topic/stainscyclind1.html)- ([Am J Surg Pathol 2017;41:1390](28622183))* [Cat scratch disease](https://www.pathologyoutlines.com/topic/lymphnodescatscratch.html):\n    + Granulomas with necrosis* [Kimura disease](https://www.pathologyoutlines.com/topic/lymphnodeskimurasdisease.html):\n      + Lacks a significant population of Langerhans cells* [Juvenile xanthogranuloma](https://www.pathologyoutlines.com/topic/skintumornonmelanocyticjuvenilexantho.html):\n        + Benign proliferative disorder of histiocytic cells of the dermal dendrocyte phenotype (positive for [factor XIIIa](https://www.pathologyoutlines.com/topic/stainsfactorxiiia.html), a marker of interstitial dendrocytes, [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html), [CD163](https://www.pathologyoutlines.com/topic/cdmarkerscd163.html), [CD14](https://www.pathologyoutlines.com/topic/cdmarkerscd10to19.html#cd14) and [fascin](https://www.pathologyoutlines.com/topic/stainsfascin.html); negative for [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html) and [langerin](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207))* [Erdheim-Chester disease](https://www.pathologyoutlines.com/topic/lymphnodeserdheimchester.html):\n          + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-, [langerin](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)- histiocytes, including Touton type giant cells* [Rosai-Dorfman disease](https://www.pathologyoutlines.com/topic/lymphnodessinushistiocytosiswithmassivelymph.html):\n            + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-, [langerin](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)-, [S100](https://www.pathologyoutlines.com/topic/stainss100.html)+ histiocytes showing emperipolesis* **Langerhans cell sarcoma**:\n              + Pleomorphic and highly atypical Langerhans cells"
  },
  {
    "id": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt-28",
    "source_document": "langerhans-cell-histiocytic-neoplasms_31723_1750165659.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesLCH.html#additionalreferences183974",
    "clean_content": "Additional references\n\n* [Swerdlow: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition, 2016](https://www.amazon.com/exec/obidos/ASIN/928324494X/pathologyoutl-20)"
  }
]